Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell & Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York.
Related news for (GBIO)
- Today’s Top Performers: MoBot’s Market Review 08/13/25 02:00 PM
- MoBot alert highlights: NASDAQ: LGVN, NASDAQ: GBIO, NASDAQ: WBTN, NASDAQ: SHOT, NYSE: BTCM (08/13/25 10:00 AM)
- MoBot’s Stock Market Highlights – 08/12/25 05:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/12/25 04:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/16/25 05:00 PM